S117: CHEMOTHERAPY-FREE TREATMENT WITH INOTUZUMAB OZOGAMICIN AND BLINATUMOMAB FOR OLDER ADULTS WITH NEWLY-DIAGNOSED, PH-NEGATIVE, CD22-POSITIVE, B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA: ALLIANCE A041703

MLA

Matthew Wieduwilt, et al. “S117: Chemotherapy-Free Treatment with Inotuzumab Ozogamicin and Blinatumomab for Older Adults with Newly-Diagnosed, Ph-Negative, Cd22-Positive, B-Cell Acute Lymphoblastic Leukemia: Alliance A041703.” HemaSphere, vol. 7, Aug. 2023. EBSCOhost, https://doi.org/10.1097/01.HS9.0000967380.08838.b7.

APA

Matthew Wieduwilt, Jun Yin, Oudom Kour, Rebecca Teske, Wendy Stock, Ken Byrd, Kimberly Doucette, James Mangan, Gregory Masters, Alice Mims, Katarzyna Jamieson, Shira Dinner, Ali Bseiso, Geoffrey Uy, Harry Erba, Mark Litzow, & Richard Stone. (2023). S117: Chemotherapy-Free Treatment with Inotuzumab Ozogamicin and Blinatumomab for Older Adults with Newly-Diagnosed, Ph-Negative, Cd22-Positive, B-Cell Acute Lymphoblastic Leukemia: Alliance A041703. HemaSphere, 7. https://doi.org/10.1097/01.HS9.0000967380.08838.b7

Chicago

Matthew Wieduwilt, Jun Yin, Oudom Kour, Rebecca Teske, Wendy Stock, Ken Byrd, Kimberly Doucette, et al. 2023. “S117: Chemotherapy-Free Treatment with Inotuzumab Ozogamicin and Blinatumomab for Older Adults with Newly-Diagnosed, Ph-Negative, Cd22-Positive, B-Cell Acute Lymphoblastic Leukemia: Alliance A041703.” HemaSphere 7 (August). doi:10.1097/01.HS9.0000967380.08838.b7.